CLINICAL TRIALS PROFILE FOR FAMOTIDINE AND IBUPROFEN
✉ Email this page to a colleague
All Clinical Trials for FAMOTIDINE AND IBUPROFEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00450216 ↗ | Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment | Completed | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 3 | 2007-03-01 | The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibuprofen. |
NCT00450658 ↗ | Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers | Completed | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 3 | 2007-03-01 | The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibuprofen. |
NCT00613106 ↗ | Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216) | Completed | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 3 | 2007-09-01 | The purpose of this study is to evaluate the safety of long-term treatment with HZT-501. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FAMOTIDINE AND IBUPROFEN
Condition Name
Clinical Trial Locations for FAMOTIDINE AND IBUPROFEN
Trials by Country
Clinical Trial Progress for FAMOTIDINE AND IBUPROFEN
Clinical Trial Phase
Clinical Trial Sponsors for FAMOTIDINE AND IBUPROFEN
Sponsor Name